Status and phase
Conditions
Treatments
About
The purpose of this study is to compare the efficacy and safety of the fixed combination asthma drug FlutiForm with its two components administered alone, fluticasone propionate and formoterol fumarate, and with placebo in adult and adolescent patients with moderate to severe asthma.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Ages eligible for study: 12 years and above; genders eligible for study: both; prior steroid use: steroid-requiring
Inclusion Criteria:
Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
557 participants in 5 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal